Animals of the AD group displayed a dominant type-17 response, which was downregulated upon fructan administration, with a concurrent transition toward type-1 and regulatory phenotypes, with an increased expression of Il10 and Tgfb1. The gene discussed is TGFB1; the disease is Alzheimer disease.